tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

TVTX Stock Latest News

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Press ReleasesTravere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
23d ago
TVTX
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2M ago
TVTX
Travere Therapeutics Shareholders Back Management and Growth Plan
PremiumCompany Announcements
Travere Therapeutics Shareholders Back Management and Growth Plan
2M ago
8K
TVTX
Travere Therapeutics to Present at National Kidney Foundation Spring Clinical Meetings and the 61st European Renal Association Congress
PremiumPress Releases
Travere Therapeutics to Present at National Kidney Foundation Spring Clinical Meetings and the 61st European Renal Association Congress
2M ago
TVTX
Travere Therapeutics to Present at Upcoming Investor Conferences
PremiumPress Releases
Travere Therapeutics to Present at Upcoming Investor Conferences
2M ago
TVTX
Travere Therapeutics price target raised to $18 from $15 at Canaccord
PremiumThe FlyTravere Therapeutics price target raised to $18 from $15 at Canaccord
2M ago
TVTX
Travere Therapeutics reports Q1 EPS (1.51) , consensus (99c)
PremiumThe Fly
Travere Therapeutics reports Q1 EPS (1.51) , consensus (99c)
2M ago
TVTX
TVTX Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
TVTX Upcoming Earnings Report: What to Expect?
2M ago
TVTX
Travere Therapeutics to Report First Quarter 2024 Financial Results
PremiumPress Releases
Travere Therapeutics to Report First Quarter 2024 Financial Results
2M ago
TVTX
Travere Therapeutics price target raised to $19 from $17 at H.C. Wainwright
PremiumThe Fly
Travere Therapeutics price target raised to $19 from $17 at H.C. Wainwright
2M ago
TVTX
Travere Therapeutics, CSL Vifor announce EC approves FILSPARI
PremiumThe Fly
Travere Therapeutics, CSL Vifor announce EC approves FILSPARI
2M ago
TVTX
Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy
PremiumPress Releases
Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy
2M ago
TVTX
Travere Therapeutics, CSL Vifor announce EC approval for Filspari
PremiumThe FlyTravere Therapeutics, CSL Vifor announce EC approval for Filspari
2M ago
TVTX
Travere Therapeutics to Present Abstracts at the Society for Inherited Metabolic Disorders and Genetic Metabolic Dieticians International
PremiumPress Releases
Travere Therapeutics to Present Abstracts at the Society for Inherited Metabolic Disorders and Genetic Metabolic Dieticians International
3M ago
TVTX
Travere Therapeutics to Present Abstracts on FILSPARI® (sparsentan) in IgA Nephropathy at World Congress of Nephrology and the American Nephrology Nurses Association
PremiumPress Releases
Travere Therapeutics to Present Abstracts on FILSPARI® (sparsentan) in IgA Nephropathy at World Congress of Nephrology and the American Nephrology Nurses Association
3M ago
TVTX
Travere downgraded to Neutral at Guggenheim on smaller role in IgAN space
PremiumThe Fly
Travere downgraded to Neutral at Guggenheim on smaller role in IgAN space
3M ago
TVTX
Travere Therapeutics downgraded to Neutral from Buy at Guggenheim
PremiumThe Fly
Travere Therapeutics downgraded to Neutral from Buy at Guggenheim
3M ago
TVTX
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4M ago
TVTX
Travere Therapeutics submits sNDA for FILSPARI for IgAN
PremiumThe Fly
Travere Therapeutics submits sNDA for FILSPARI for IgAN
4M ago
TVTX
Travere Therapeutics Submits Supplemental New Drug Application to the U.S. Food and Drug Administration Seeking Full Approval of FILSPARI® (sparsentan) for the Treatment of IgA Nephropathy (IgAN)
PremiumPress ReleasesTravere Therapeutics Submits Supplemental New Drug Application to the U.S. Food and Drug Administration Seeking Full Approval of FILSPARI® (sparsentan) for the Treatment of IgA Nephropathy (IgAN)
4M ago
TVTX
Travere Therapeutics to Present at Upcoming Investor Conferences
PremiumPress Releases
Travere Therapeutics to Present at Upcoming Investor Conferences
4M ago
TVTX
Travere’s Sparsentan Nears European Market Breakthrough
PremiumCompany Announcements
Travere’s Sparsentan Nears European Market Breakthrough
4M ago
8K
TVTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >